Our findings suggested that CA125 was positively correlated with tumor size, differentiation, tumor capsulation, and TNM stage, which means that ICC patients with elevated CA125 might have a larger tumor burden and earlier recurrence or metastasis. This evidence concerns the gene MUC16 and intrahepatic cholangiocarcinoma.